ARGENE® Respiratory

ARGENE^® Respiratory

R-GENE^® Respiratory PCR Kits

ARGENE^® Respiratory includes ready-to-use real-time PCR detection kits for viral respiratory diseases.

Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.

ARGENE Respiratory Range

Overview
Assays
Resources

Overview

Targeted Diagnostic Strategy with an “A La Carte” Menu

Respiratory pathogens have variable seasonalities with some being present throughout the year and others present during epidemic outbreaks. Diagnostic strategies can be adapted to the season by searching for the most likely pathogens in 1^st intention and the remaining pathogens in 2^nd intention.

Everything You Need in One Kit

R-GENE^® kits include all necessary reagents:

Ready-to-use amplification premix (including Taq polymerase)
Reverse transcriptase
Positive control
Negative control

Easy Procedure

Using R-GENE^® assay is easy.

ARGENE^® Expertise

Simplicity: complete kits, ready-to-use reagents, same pipetting procedure
Seamless Integration: validated for use on multi-specimens, multi-extraction, and multi-amplification platforms
Lab Efficiency: common internal control, harmonized extraction and amplification protocols, multiple targeted detection from one extracted sample

Assays

Kit Designation	Reference	Type of Kit	Number of Tests	Regulatory Status*
SARS-COV-2/FLUA/FLUB/RSV R-GENE^®	424433	Real-time Detection Kit	96	For in vitro diagnostic use (IVDR)
COVID-19 R-GENE^®	424017	Real-time Detection Kit	96	For in vitro diagnostic use (IVDR)
RHINO&EV/CC R-GENE^®	71-042	Real-time Detection Kit	60	For in vitro diagnostic use (IVDR)

SARS-COV-2/FLUA/FLUB/RSV R-GENE^®
PCR DESIGN	5-PLEX SARS-CoV-2 Influenza A Influenza B RSV Endogenous Internal Control
TARGETED GENES	SARS-CoV-2: N & RdRp genes Influenza A: M gene Influenza B: M gene RSV: M gene Endogenous Internal Control: HPRT1 gene
CONTROLS INCLUDED	Positive Control, Negative Control, Endogenous Internal Control
SPECIMENS	Nasopharyngeal Swab
EXTRACTION PLATFORMS	EMAG^® NUCLISENS^® easyMAG^® QIAsymphony SP MagNA Pure 96 MGISP‑960
AMPLIFICATION PLATFORMS	QuantStudio 5 QuantStudio 5 Dx CFX 96 CFX Opus 96
RESULT WITHIN	90 minutes after extraction
STORAGE CONDITIONS	-15°C / -31°C
STATUS	For in vitro diagnostic use (IVDR, CE marked under EU IVD regulation 2017/746)

COVID-19 R-GENE^®
PCR DESIGN	2-PLEX SARS-CoV-2 Endogenous Internal Control
TARGETED GENES	SARS-CoV-2: N & RdRp genes Endogenous Internal Control: HPRT1 gene
CONTROLS INCLUDED	Positive Control, Negative Control, Endogenous Internal Control
SPECIMENS	Nasopharyngeal Swab Saliva
EXTRACTION PLATFORMS	EMAG^® NUCLISENS^® easyMAG^® QIAsymphony SP MagNA Pure 96 MGISP‑960
AMPLIFICATION PLATFORMS	QuantStudio 5 QuantStudio 5 Dx CFX 96 CFX Opus 96 7500 Fast 7500 Fast Dx LightCycler 480 (System II) Rotor‑Gene Q
RESULT WITHIN	90 minutes after extraction
STORAGE CONDITIONS	-15°C / -31°C
STATUS	For in vitro diagnostic use (IVDR, CE marked under EU IVD regulation 2017/746)

RHINO&EV/CC R-GENE^®
PCR DESIGN	2-PLEX Rhino&EV Endogenous Internal Control
TARGETED GENES	Rhinovirus A/B/C: non coding 5' region Enterovirus A/B/C/D: non coding 5' region Endogenous Internal Control: HPRT1 gene
CONTROLS INCLUDED	Positive Control, Negative Control, Endogenous Internal Control
SPECIMENS	Nasopharyngeal Swab Nasopharyngeal Aspirate Bronchoalveolar Lavage
EXTRACTION PLATFORMS	EMAG^® NUCLISENS^® easyMAG^® QIAsymphony SP
AMPLIFICATION PLATFORMS	QuantStudio 5 QuantStudio 5 Dx CFX 96 CFX Opus 96 7500 Fast 7500 Fast Dx LightCycler 480 (System II) Rotor‑Gene Q
RESULT WITHIN	120 minutes after extraction
STORAGE CONDITIONS	-15°C / -31°C
STATUS	For in vitro diagnostic use (IVDR, CE marked under EU IVD regulation 2017/746)

Resources

SARS-COV-2 FLUA FLUB RSV R-GENE^® Brochure

Download

COVID-19 R-GENE^® Brochure

Download

Global COVID-19 Map

Download

Related Products

EMAG^®

EMAG^® offers efficient and flexible extraction to manage both routine and challenging customer needs, supported by a committed and skilled team at bioMérieux.

LEARN MORE

BIOFIRE^® Respiratory 2.1 (RP2.1) & Respiratory 2.1 plus (RP2.1plus) Panels

The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

LEARN MORE

COVID-19 Testing Solutions for Healthcare

Because every COVID-19 patient comes with a unique profile and experiences the disease differently, patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.

LEARN MORE